glp-1 fertility Medications and Your Journey Recent research continues to reframe

Short-acting GLP-1RAs (exenatide [ t 1/2 of 2.4 hours] and lixisenatide [ t 1/2 of 24 hours] administered before meals twice-daily and once-daily, respectively) exhibit intermittent GLP-1 receptor activation translating into potent deceleration of upper gastrointestinal motility, an effect which is sustained during prolonged treatment

Patient experience with hyperphagia is a modifier in how much risk caregivers will accept

The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months

High-protein foods tend to be better tolerated than carbohydrate-heavy meals during the adjustment period

In our clinic, we treat GLP-1 nausea as a problem to address actively, not as an inevitable cost of the medication